BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2005401)

  • 21. Differential induction of adrenomedullin, interleukins and tumour necrosis factor-alpha by lipopolysaccharide in rat tissues in vivo.
    Li YY; Wong LY; Cheung BM; Hwang IS; Tang F
    Clin Exp Pharmacol Physiol; 2005 Dec; 32(12):1110-8. PubMed ID: 16445578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice.
    Tsutsui H; Matsui K; Kawada N; Hyodo Y; Hayashi N; Okamura H; Higashino K; Nakanishi K
    J Immunol; 1997 Oct; 159(8):3961-7. PubMed ID: 9378984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic interactions of interleukin 1, interferon-beta, and tumor necrosis factor in terminally differentiating a mouse myeloid leukemic cell line (M1). Evidence that interferon-beta is an autocrine differentiating factor.
    Onozaki K; Urawa H; Tamatani T; Iwamura Y; Hashimoto T; Baba T; Suzuki H; Yamada M; Yamamoto S; Oppenheim JJ
    J Immunol; 1988 Jan; 140(1):112-9. PubMed ID: 3275716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cells.
    Ucla C; Roux-Lombard P; Fey S; Dayer JM; Mach B
    J Clin Invest; 1990 Jan; 85(1):185-91. PubMed ID: 2104878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals.
    Kim CK; Rivier C
    J Neuroendocrinol; 1998 May; 10(5):353-62. PubMed ID: 9663649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. beta(2)-adrenoceptor agonist suppresses renal tumour necrosis factor and enhances interleukin-6 gene expression induced by endotoxin.
    Nakamura A; Johns EJ; Imaizumi A; Yanagawa Y; Kohsaka T
    Nephrol Dial Transplant; 2000 Dec; 15(12):1928-34. PubMed ID: 11096136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endotoxin induction of murine metallothionein gene expression.
    De SK; McMaster MT; Andrews GK
    J Biol Chem; 1990 Sep; 265(25):15267-74. PubMed ID: 2203773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The intratracheal administration of endotoxin and cytokines. I. Characterization of LPS-induced IL-1 and TNF mRNA expression and the LPS-, IL-1-, and TNF-induced inflammatory infiltrate.
    Ulich TR; Watson LR; Yin SM; Guo KZ; Wang P; Thang H; del Castillo J
    Am J Pathol; 1991 Jun; 138(6):1485-96. PubMed ID: 2053596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endotoxin and cytokines increase hepatic messenger RNA levels and serum concentrations of apolipoprotein J (clusterin) in Syrian hamsters.
    Hardardóttir I; Kunitake ST; Moser AH; Doerrler WT; Rapp JH; Grünfeld C; Feingold KR
    J Clin Invest; 1994 Sep; 94(3):1304-9. PubMed ID: 8083372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endotoxin-induced cytokine gene expression in vivo. I. Expression of tumor necrosis factor mRNA in visceral organs under physiologic conditions and during endotoxemia.
    Ulich TR; Guo K; del Castillo J
    Am J Pathol; 1989 Jan; 134(1):11-4. PubMed ID: 2643883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Central endotoxin induces different patterns of interleukin (IL)-1 beta and IL-6 messenger ribonucleic acid expression and IL-6 secretion in the brain and periphery.
    De Simoni MG; Del Bo R; De Luigi A; Simard S; Forloni G
    Endocrinology; 1995 Mar; 136(3):897-902. PubMed ID: 7867598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Orbital fibroblast interleukin-6 gene expression and immunomodulation.
    Burnstine MA; Elner SG; Strieter RM; Kunkel SL; Elner VM
    Ophthalmic Plast Reconstr Surg; 1999 Sep; 15(5):306-11. PubMed ID: 10511209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo.
    Shalaby MR; Waage A; Aarden L; Espevik T
    Clin Immunol Immunopathol; 1989 Dec; 53(3):488-98. PubMed ID: 2805453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects.
    Urbaschek R; Urbaschek B
    Rev Infect Dis; 1987; 9 Suppl 5():S607-15. PubMed ID: 3317753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-derived products induce Il-1 a, Il-1 b, Tnf a, and Il-6 gene expression in murine macrophages: distinctions between tumor- and bacterial endotoxin-induced gene expression.
    Evans R; Kamdar SJ; Duffy TM
    J Leukoc Biol; 1991 May; 49(5):474-82. PubMed ID: 2016568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor necrosis factor induces skeletal muscle protein breakdown in rats.
    Goodman MN
    Am J Physiol; 1991 May; 260(5 Pt 1):E727-30. PubMed ID: 2035628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time course of IL-6 and TNF alpha release during endotoxin-induced endotoxin tolerance in rats.
    Flohé S; Heinrich PC; Schneider J; Wendel A; Flohé L
    Biochem Pharmacol; 1991 Jun; 41(11):1607-14. PubMed ID: 1710458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating interleukin 1 and tumor necrosis factor during inflammation.
    Moldawer LL; Gelin J; Scherstén T; Lundholm KG
    Am J Physiol; 1987 Dec; 253(6 Pt 2):R922-8. PubMed ID: 3501249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of serum Interleukin-1-like activity after treatment with dexamethasone.
    Staruch MJ; Wood DD
    J Leukoc Biol; 1985 Feb; 37(2):193-207. PubMed ID: 3871468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The mediation of endotoxin-induced beneficial effects by cytokines.
    Urbaschek R; Urbaschek B
    Adv Exp Med Biol; 1990; 256():549-56. PubMed ID: 2183565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.